WATSON 796 (Sulfasalazine 500 mg)
Pill imprint WATSON 796 has been identified as Sulfasalazine 500 mg.
Sulfasalazine is used in the treatment of rheumatoid arthritis; ulcerative colitis, active; alopecia; crohn's disease, acute; psoriatic arthritis (and more), and belongs to the drug classes 5-aminosalicylates, sulfonamides. There is no proven risk in humans during pregnancy. Sulfasalazine 500 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
- 500 mg
- 13.00 mm
- Prescription only
sodium starch glycolate type A potato
More about sulfasalazine
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.